Filing Flows › Veracyte (VCYT) › Testing revenue revenue
Veracyte (VCYT) Testing revenue revenue by quarter
Veracyte's Testing revenue revenue was $146M in Q3 2026 (third quarter 2026), +0.5% from Q2 2026. Over the last 7 quarters it ranged from $107M (Q1 2025) to $146M (Q3 2026).
| Quarter | Testing revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $146M | +0.5% | +15% |
| Q2 2026 | $146M | +8% | +19% |
| Q1 2026 | $135M | -0.5% | +26% |
| Q4 2025 | $136M | +6% | — |
| Q3 2025 | $128M | +4% | — |
| Q2 2025 | $122M | +14% | — |
| Q1 2025 | $107M | — | — |
Q3 2026 at a glance
Veracyte, Q3 2026: revenue $152M (+15% year over year), operating margin 10.9%, net earnings $31.5M, operating cash flow $40.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Veracyte's Testing revenue revenue?
Veracyte's Testing revenue revenue was $146M in Q3 2026 (third quarter 2026), +0.5% from Q2 2026.
How has Veracyte's Testing revenue revenue changed?
Over the last 7 quarters it ranged from $107M (Q1 2025) to $146M (Q3 2026).